SD
Srikripa Devarakonda Truist Securities Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
30
Avg Return
Past Year
Past Year
33%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
83.3%
Neutral
16.7%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Hold
Maintained
| $190 |
16%
upside
| 1 | +23% |
0
%
| 8 Jan ‘26 10 days ago |
|
|
|
Buy
Maintained
| $110 |
34%
upside
| 2 | +15% |
0
%
| 5 Jan ‘26 13 days ago |
|
|
|
Buy
Initiated
| $34 |
30%
upside
| 1 | +2.5% |
0
%
| 15 Dec ‘25 1 month ago |
|
|
|
Buy
Maintained
| $116 |
67%
upside
| 2 | +9.8% |
0
%
| 9 Dec ‘25 1 month ago |
|
|
|
Buy
Maintained
| $56 |
53%
upside
| 3 | +52% |
0
%
| 9 Dec ‘25 1 month ago |
|
|
|
Buy
Maintained
| $640 |
28%
upside
| 1 | +8.8% |
0
%
| 19 Nov ‘25 2 months ago |
|
|
|
Hold
Reiterated
| $93 |
12%
downside
| 1 | – |
–
| 29 Oct ‘25 2 months ago |
|
|
|
Buy
Maintained
| $44 |
2%
downside
| 1 | +61% |
0
%
| 20 Oct ‘25 3 months ago |
|